Cosmos Health (COSM) Projects $6M Revenue from Oliv18 Launch

Cosmos Health (COSM) anticipates $6 million in revenue from the launch of its Oliv18 supplement. This projection is part of the company’s growth strategy in the health and wellness sector. The launch of Oliv18 aims to leverage increasing consumer demand for dietary supplements. This expected revenue could positively influence investor sentiment and market performance for Cosmos Health.